THE CHROMOSOME | Clinical Content Series
Hypogonadism
Back to Case Studies ArchiveCase Study
He was 38 years old and had not felt like himself in four years. That was how he described it, not like himself. He had gained 26 kilograms without any meaningful change in his diet or activity. His energy was gone. His motivation had disappeared. He had lost interest in his work, in his marriage, in the things that had once defined him. He slept poorly. He felt low in a way he could not articulate to his wife or his friends. He had been told he was depressed. He had been given antidepressants by two different physicians. Neither had helped.
He came to me not because he thought it was a hormonal problem. He came because a colleague had told him I asked different questions than other doctors. That was enough.
When I sat with him the clinical picture assembled itself quickly. The pattern of weight gain, predominantly abdominal, with loss of muscle definition across the chest and arms. The fatigue that was worst in the morning and did not improve with rest. The low mood that had no clear psychological origin. The reduced libido he mentioned quietly, almost as an afterthought, as though he expected me to dismiss it.
I did not dismiss it. In my experience it is almost always the detail the patient mentions last that is most clinically significant.
His total testosterone was severely low. His LH and FSH were inappropriately normal for that level of testosterone, indicating a secondary hypogonadism in which the pituitary was failing to drive adequate testicular production. His SHBG was elevated, further reducing the already depleted fraction of testosterone available to his tissues. His metabolic profile confirmed what I had expected, significant insulin resistance, elevated inflammatory markers, and a visceral fat distribution entirely consistent with prolonged testosterone deficiency.
This was not depression. This was hypogonadism, and it had been driving his weight gain, his fatigue, his low mood, and his metabolic deterioration for years while he was being treated for a psychological condition he did not have.
The FTO gene's influence on hypothalamic pituitary gonadal axis regulation is something I observe consistently in Pakistani men presenting with this picture. The metabolic predisposition creates a pathway in which visceral fat accumulation drives oestrogen production through peripheral conversion, which suppresses testosterone further, which promotes more visceral fat, a closed hormonal loop that tightens with every passing year of inadequate treatment.
We restored his testosterone through the appropriate clinical pathway. We simultaneously addressed his insulin resistance, his visceral fat, and his inflammatory load. We did not touch his antidepressants immediately, but within six months he had discontinued them himself, under medical supervision, because he no longer needed them.
Thirteen months after his first visit he had lost 22 kilograms. His energy had returned. His marriage had improved. He had gone back to the work he loved.
He had not been depressed. He had been undertreated. There is a significant difference.
FAQs
Hypogonadism is a condition in which the testes produce insufficient testosterone, either because of a primary failure of the testes themselves or because the pituitary gland is not sending adequate stimulating signals. Testosterone governs muscle mass, fat distribution, metabolic rate, mood, energy, and libido. When it falls, every one of these functions deteriorates simultaneously. In Pakistani men, hypogonadism is a significantly underdiagnosed cause of progressive abdominal obesity, because its symptoms are attributed to stress, ageing, or depression, and testosterone is rarely measured as part of a standard metabolic evaluation. Dr. Zaar identifies low testosterone as both a driver and a consequence of obesity in a substantial proportion of his male Pakistani patients.
Testosterone is a primary regulator of body composition, it promotes muscle development and directly inhibits visceral fat accumulation. When testosterone falls, muscle mass decreases, resting metabolic rate drops, and fat storage in the abdominal region accelerates. The visceral fat that accumulates then converts testosterone to oestrogen through a process called peripheral aromatisation, further suppressing testosterone and deepening the hormonal imbalance. This self reinforcing cycle tightens progressively without intervention. Pakistani men in this cycle gain weight despite normal or reduced food intake, lose muscle despite physical activity, and deteriorate metabolically at a rate that dietary intervention alone cannot reverse.
The FTO gene at Chromosome 16q12.2 influences hypothalamic regulation of the entire endocrine axis, including the signals that govern LH and FSH production from the pituitary and the subsequent testosterone output from the testes. In Pakistani men, the FTO associated metabolic profile creates a predisposition to hypothalamic pituitary dysfunction that reduces gonadotropin signalling at lower levels of metabolic stress than seen in Western populations. Dr. Zaar's clinical experience consistently shows that Pakistani men with the FTO linked metabolic profile develop secondary hypogonadism earlier, at lower degrees of obesity, and with more profound metabolic consequences than global clinical literature anticipates.
The symptomatic overlap between hypogonadism and depression is almost complete, low mood, fatigue, loss of motivation, social withdrawal, sleep disruption, and reduced interest in previously enjoyed activities are common to both. Pakistani men are also culturally less likely to volunteer symptoms of reduced libido or sexual dysfunction to a physician, meaning the most diagnostically specific symptom of hypogonadism is frequently never discussed. Antidepressants treat the mood without addressing the hormonal failure, producing partial and temporary improvement while the testosterone deficiency and its metabolic consequences continue to worsen. Dr. Zaar measures testosterone in every Pakistani man presenting with unexplained fatigue, weight gain, or low mood as a standard diagnostic step.
Visceral fat is an endocrine organ that actively converts testosterone to oestrogen through the enzyme aromatase, the more visceral fat present, the greater the conversion and the lower the available testosterone. Elevated oestrogen then feeds back to the hypothalamus and pituitary, suppressing the LH signal that drives testicular testosterone production. Simultaneously, the chronic inflammation generated by visceral fat directly impairs testicular Leydig cell function, the cells responsible for testosterone synthesis. Insulin resistance, almost universally present in obese Pakistani men, further suppresses testosterone production independently. Every kilogram of visceral fat a Pakistani man carries actively works to reduce his testosterone, which in turn promotes further visceral fat accumulation.
In cases of secondary hypogonadism where the testicular tissue remains functional, meaningful testosterone recovery is achievable through comprehensive metabolic intervention, visceral fat reduction, insulin resistance treatment, inflammatory load reduction, sleep restoration, and cortisol management. Each of these interventions removes a suppressive influence on the hypothalamic pituitary gonadal axis, allowing endogenous testosterone production to recover. Dr. Zaar pursues metabolic restoration as the first line intervention in appropriate patients before considering testosterone replacement therapy, because restoring the body's own production is always preferable to replacing it externally. Where replacement is indicated, it is managed within the comprehensive hormonal framework of THE CHROMOSOME protocol.
Untreated hypogonadism in the context of obesity and metabolic dysfunction creates a trajectory toward type 2 diabetes, cardiovascular disease, osteoporosis, severe metabolic syndrome, and progressive cognitive decline. In Pakistani men, where testosterone deficiency is rarely diagnosed and even more rarely treated comprehensively, these consequences accumulate silently across the fourth and fifth decades of life, emerging as major health events in the fifties and sixties that are entirely preventable with earlier intervention. Dr. Zaar treats hypogonadism as a serious metabolic condition with long term systemic consequences, not as a lifestyle complaint or an inevitable consequence of ageing. The Pakistani man who presents with unexplained weight gain and fatigue at 38 is not simply getting older. He may be in the early stages of a hormonal deterioration that, left unaddressed, will define the rest of his health.
Testosterone is essential for bone density maintenance in men, it stimulates bone forming cells and inhibits bone resorption. In hypogonadal Pakistani men, prolonged testosterone deficiency produces progressive bone loss that is rarely investigated because osteoporosis is considered a condition of women and older men. The combination of low testosterone, elevated oestrogen from visceral fat aromatisation, vitamin D deficiency, extremely prevalent in Pakistan, and chronic inflammation from visceral obesity creates a bone health crisis that operates silently for years before manifesting as fractures or severe osteopenia. THE CHROMOSOME protocol includes bone density assessment and vitamin D optimisation as standard components of hypogonadism management in Pakistani male patients.